Ponatinib for Squamous Cell Lung and Head and Neck Cancers

Clinical trial NCT01761747 · TERMINATED

Trial details

NCT number: NCT01761747
Sponsor: Dana-Farber Cancer Institute
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer, Head and Neck Cancer

Start date: 2013-01-01
Primary completion: 2014-06-01
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.